Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DDXSQ
diaDexus
$0.00
$0.00
$0.00
N/AN/AN/A100 shs
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$107.68
$106.87
$100.01
$112.30
N/A-0.02106 shsN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
$0.00
$0.00
$0.00
N/AN/A1.00 million shsN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
$0.00
$0.00
$0.01
N/AN/AN/AN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DDXSQ
diaDexus
0.00%0.00%0.00%0.00%0.00%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
0.00%0.00%+2.85%-1.75%-1.21%
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
0.00%0.00%0.00%0.00%0.00%
Avivagen Inc. stock logo
VIVXF
Avivagen
0.00%0.00%0.00%0.00%-97.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DDXSQ
diaDexus
N/AN/AN/AN/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/AN/AN/AN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DDXSQ
diaDexus
0.00
N/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
2.00
HoldN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
0.00
N/AN/AN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DDXSQ
diaDexus
N/AN/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$1.24BN/A$9.09 per share11.85N/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/AN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
$730KN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DDXSQ
diaDexus
N/AN/A0.00N/AN/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$173.01MN/A0.00N/AN/AN/AN/A7/28/2025 (Estimated)
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
-$4.71MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DDXSQ
diaDexus
N/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/AN/AN/AN/AN/A
Avivagen Inc. stock logo
VIVXF
Avivagen
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
DDXSQ
diaDexus
N/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
N/A
Avivagen Inc. stock logo
VIVXF
Avivagen
N/A

Insider Ownership

CompanyInsider Ownership
DDXSQ
diaDexus
4.42%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/A
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
6.03%
Avivagen Inc. stock logo
VIVXF
Avivagen
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
DDXSQ
diaDexus
38N/AN/ANot Optionable
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
3,186N/AN/ANot Optionable
Hybrid Energy Holdings Inc. stock logo
HYBE
Hybrid Energy
1N/AN/ANot Optionable
Avivagen Inc. stock logo
VIVXF
Avivagen
13N/AN/ANot Optionable

Recent News About These Companies

CYTO:CA Cytophage Technologies Ltd.
Avivagen to Attend CEM Sponsored Alpha North Conference

Media Sentiment Over Time

diaDexus OTCMKTS:DDXSQ

Diadexus, Inc., a diagnostics company, focuses on the development and commercialization of cardiovascular diagnostic products addressing needs in cardiovascular disease. Its products include PLAC ELISA Test and the PLAC Activity Test that are designed to provide information on traditional risk factors, such as cholesterol levels to help identify individuals at risk of suffering a heart attack or stroke. The company's PLAC ELISA Test is an aid in predicting risk for coronary heart disease (CHD) and ischemic strokes associated with atherosclerosis; and PLAC Test for Lp-PLA2 (lipoprotein-associated phospholipase A2) Activity is used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of CHD in patients with no prior history of cardiovascular events. Its pipeline of proprietary biomarkers comprises proADM, proET-1, and proANP for the treatment of heart failure. The company markets its products to various national and regional clinical reference laboratories and hospitals in the United States, Europe, and internationally. The company is based in Poway, California. On June 13, 2016, Diadexus, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Northern District of California.

DiaSorin stock logo

DiaSorin OTCMKTS:DSRLF

$107.68 0.00 (0.00%)
As of 06/26/2025

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Hybrid Energy stock logo

Hybrid Energy OTCMKTS:HYBE

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.

Avivagen stock logo

Avivagen OTCMKTS:VIVXF

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.